FZD6 and acute myeloid leukemia: Age (hazard ratio (HR) = 1.018, 95% CI: 1.001-1.035, P = 0.040), WBC counts (HR = 1.007, 95% CI: 1.002-1.011, P = 0.040), ELN risk stratification (HR = 2.720, 95% CI: 1.341-5.518, P = 0.006), induction therapy (HR = 0.371, 95% CI: 0.211-0.654, P = 0.001), HSCT (HR = 0.508, 95% CI: 0.304-0.848, P = 0.010), and FZD6 expression (HR = 1.264, 95% CI: 1.025-1.559, P = 0.028) were the independent prognosis factors of OS in AML patients.